News
1d
MedPage Today on MSNNovel DPP-1 Drug Trims Exacerbation Risk in BronchiectasisThe dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...
A phase 2 trial evaluated peanut OIT in adults with peanut-allergic using real-world peanut products, employing a Simon’s minimax two-stage design with stop:go futility analysis. Participants ...
6d
Verywell Health on MSNDaily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly SaysA new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results